• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Chris Newmarker

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Abbott launches universal FreeStyle Libre CGM app in U.S.

April 21, 2025 By Chris Newmarker

This is an Abbott marketing image showing its new Libre app running on a smartphone with a Freestyle Libre sensor leaning against it.

Abbott (NYSE: ABT) recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 continuous glucose monitoring systems. “By listening to our customers, we developed a universal app with enhanced features to make living with diabetes easier,” Badia Boudaiffa, VP of North America commercial operations for Abbott’s diabetes care […]

Filed Under: Diabetes, Featured, Technology Tagged With: abbott, CGM

BD to close infusion and syringe pumps facility in Israel

January 27, 2025 By Chris Newmarker

This is the logo of BD.

BD (NYSE: BDX) plans to close a facility in Caesarea, Israel, by the middle of the year.  Calcalist’s CTech out of Israel reported the news earlier today, saying that the closure affects 200 employees who will be let go. BD acquired the facility through its 2017 acquisition of Caesarea Medical Electronics, maker of infusion and syringe pumps and accessories for home […]

Filed Under: Business/Financial News, Featured Tagged With: BD

BD hit with FDA warning related to Pyxis medication management

December 23, 2024 By Chris Newmarker

This is the logo of BD.

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of its $12 billion CareFusion acquisition in 2015. The warning letter, dated Nov. 22 and posted on Dec. 17, involves inspections conducted in May at a former CareFusion facility in San Diego. It notes near […]

Filed Under: Featured, Regulatory/Compliance, Technology Tagged With: BD

Insulet preliminary Q2 revenue report beats The Street

July 26, 2024 By Chris Newmarker

Insulet logo

Insulet (Nasdaq: PODD) saw its revenue increase 23% year-over-year to $488 million in the second quarter, which ended June 30. That’s according to preliminary Q2 revenue numbers that Insulet released today. The result beats the consensus of Wall Street analysts, who expected that Insulet had $460.27 million in revenue in Q2. The maker of Omnipod […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

Abbott wins FDA clearance for its Lingo OTC glucose monitor

June 3, 2024 By Chris Newmarker

This is an Abbott marketing image of its Lingo over-the-counter continuous glucose monitoring system.

Abbott (NYSE: ABT) has secured a 510(k) clearance from the FDA for its over-the-counter Lingo glucose-monitoring biowearable.  The clearance came on May 29, according to a listing on the FDA’s website. An Abbott spokesperson said the company was aware of the clearance and would provide more details later. FDA clearance for Abbott’s Lingo comes more […]

Filed Under: Diabetes, Diagnostics, Featured, Regulatory/Compliance Tagged With: abbott, CGM

ICU Medical’s Smiths Medical has a major syringe pump recall

February 15, 2024 By Chris Newmarker

This is the logo of ICU Medical.

The FDA this week said it’s designated an ICU Medical and Smiths Medical recall of Medfusion syringe pumps as Class I, the agency’s most serious level of medical device recall. The recall involves more than 50,000 Medfusion Model 4000 syringe infusion pumps in the U.S. that were distributed from Nov. 16, 2010, to July 28, […]

Filed Under: Drug-Device Combinations, Recalls Tagged With: ICU Medical

Fractyl Health goes the IPO route

February 2, 2024 By Chris Newmarker

This is the logo of Fractyl Health.

Fractyl Health — developer of medtech and gene therapies to reverse diabetes and obesity — began trading on the Nasdaq today under the symbol GUTS. Lexington, Massachusetts–based Fractyl Health priced its 7,333,333 shares of common stock at $15 per share, enabling it to bring in about $110 million from the IPO. The company expected the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO) Tagged With: Fractyl Health

FDA clears VVT Medical varicose veins treatment device

September 5, 2023 By Chris Newmarker

This VVT marketing image shows the ScleroSafe inverse action dual syringe platform to provide ECA treatment for varicose veins.

VVT Medical announced in recent months that FDA has cleared its ScleroSafe platform, which delivers endovenous chemical ablation to treat superficial varicose veins. Kfar Saba, Israel–based VVT Medical says it specifically created ScleroSafe to provide efficient, non-thermal, non-tumescent treatment and management of varicosities in superficial veins. Its inverse-action dual syringe injects the ECA substance into […]

Filed Under: Drug-Device Combinations, Featured, Regulatory/Compliance, Vascular Tagged With: VVT Medical

Bayer is making a big digital health play

June 1, 2023 By Chris Newmarker

Bayer announced that it has launched a business unit that will focus on precision digital health products across a range of everyday health categories. Bayer will prioritize developing digital solutions that enable people to make more informed health choices based on personal insights and novel delivery mechanisms, the company said in a news release posted yesterday. A […]

Filed Under: Imaging Tagged With: Bayer

Tandem reports positive research for its artificial pancreas tech

April 17, 2023 By Chris Newmarker

Tandem Diabetes Care t:slim 2 Control-IQ artificial pancreas

Tandem Diabetes Care (Nasdaq:TNDM) today announced a positive meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The research found immediate and sustained improvements for a diverse range of subjects using Control-IQ technology, according to the research published in the journal Diabetes Technology & Therapeutics. There was an average increase in […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured Tagged With: artificial pancreas, Dexcom, Tandem Diabetes Care

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 11
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS